MDHearing VoltMax vs Yeasound RIC700

The MDHearing VoltMax is a behind-the-ear OTC hearing aid priced at $699, earning a B grade with a SoundScore of 3.0/5 in our lab testing. This places it in the lower tier of the OTC hearing aid category, ranking 62nd out of 65 devices tested. In our testing, the VoltMax delivered mixed results across key performance areas. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—above the category average by 0.46 points. This means users can expect stable performance without whistling or squealing during typical daily activities. However, speech clarity proved challenging, with speech-in-quiet scoring 1.9/5 (0.93 points below category average) and speech-in-noise at 1.0/5 (0.48 points below average). Own-voice comfort measured 2.4/5, slightly below the category norm. A significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average. Users who prioritize phone streaming for calls or media should consider alternatives. The device features rechargeable batteries, offering convenience over disposable options. At this price point, several competitors deliver substantially stronger overall performance. The VoltMax may appeal to budget-conscious consumers who primarily need basic amplification with reliable feedback control and don't require streaming capabilities. Those seeking better speech clarity or music streaming should explore higher-scoring options in this price range.

The Yeasound RIC700 is a budget-priced OTC hearing aid that delivers A-grade performance in HearAdvisor's lab testing, placing it in the top 14% of the 65 OTC devices we've evaluated. At $399, it offers strong value for consumers seeking quality amplification without prescription-level costs. In our testing, the RIC700 excels at speech clarity in quiet environments, scoring 4.2/5—a strong result that sits 1.41 points above the OTC category average. Speech understanding in noisy settings scores 1.9/5, which is above the category average but remains low in absolute terms, a common limitation across OTC devices. Music streaming quality reaches 2.9/5, nearly a full point above the category average, though still mixed overall. Feedback handling is excellent at 4.6/5. The device does show some limitations. Own-voice comfort scores 2.0/5, falling 0.51 points below the category average—users may notice some occlusion effects when speaking. This behind-the-ear style features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The RIC700 competes well within its price bracket, though shoppers should note that the higher-ranked Yeasound RIC800 and Sony CRE-E10 are available at similar price points with stronger overall scores. For budget-conscious consumers prioritizing speech clarity in quieter listening situations, the RIC700 represents a solid option in the OTC market.